Compositions and methods of treating muscle atrophy and myotonic dystrophy
US11712478B2 · kind B2 · utility
0Cited by
149References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2021 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Oct 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.